FindTrial
Sign In

The effects of Swastha Thriphala®, an Ayurveda medicinal formulation on blood lipids

The effects of an Ayurveda medicinal formulation, Swastha Thriphala ® on blood lipids in patients on atorvastatin for hyperlipidaemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2013/027
Enrollment
Unknown
Registered
2013-09-03
Start date
2013-09-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidaemia

Interventions

Participants will be randomized into two arms. The intervention arm will receive Swastha Thriphala ®, 1-4 tablets (dose to be decided by the patient) to be taken daily at bedtime for 12 weeks. The

Sponsors

Link Natural Products (Pvt) Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female patients 2. On atorvastatin 3. Giving informed written consent.

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Intended pregnancy 3. Lactation 4. Participants on any other allopathic or herbal medications that may affect blood lipids

Design outcomes

Primary

MeasureTime frame
Change in blood lipids: total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. [At recruitment, 6 weeks and 12 weeks of treatment]—

Secondary

MeasureTime frame
Improvement in quality of life variables (sleep, appetite, daily activities of living, bowel movements, fatigue, mental worry, concerns about future, family life), [At recruitment, 6 weeks and 12 weeks of treatment]—

Countries

Sri Lanka

Contacts

Public ContactProfessor. C de FW Goonaratna

Registrar, Ceylon Medical College Council

si7np5e@gmail.com+9411-4612643

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026